Asston Pharmaceuticals shareholding pattern
APL
81
1.71 (-2.07%)Last updated on 20 Feb, 2026 | 15:14 IST
BUYSELL
Free Demat with Zero AMC*
Summary
For Year 2025-26, Asston Pharmaceuticals reports the following shareholding: Total Promoters at 50.66%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 6.04%, Domestic Institutional Investors at 0%, and Retail at 43.3%. This breakdown provides a quick snapshot of ownership distribution for Asston Pharmaceuticals in 2025-26.
Asston Pharmaceuticals FAQs
As of 02-2026, the promoter shareholding in Asston Pharmaceuticals stands at 50.66% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Asston Pharmaceuticals is 6.04% and 0% respectively.
The retail shareholding of the Asston Pharmaceuticals is 43.3%.
Changes in shareholding patterns of Asston Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Asston Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Asston Pharmaceuticals Associated Pages
